Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haas

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Investigative Radiology|September 10, 2003
Noninvasive diagnosis of arthritis by autofluorescenceAndreas Hansch, Dieter Sauner, Ingrid Hilger, et al.
Arthritis and Rheumatism|March 17, 2004
In vivo imaging of experimental arthritis with near-infrared fluorescenceAndreas Hansch, Oliver Frey, Dieter Sauner, et al.
World Journal of Gastroenterology|August 26, 2014
Translational research in pancreatic ductal adenocarcinoma: current evidence and future conceptsStephan Kruger, Michael Haas, Steffen Ormanns, et al.
International Journal of Molecular Medicine|November 13, 2003
Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesisWichard Vogel, Alexander Berndt, Angelika Müller, et al.
ACS Macro Letters|May 25, 2022
A Priori Prediction of Mass Spectrometric Product Patterns of Photoinitiated PolymerizationsPhilipp Jöckle, Judith Radebner, Michael Haas, et al.
Bioorganic & Medicinal Chemistry|August 21, 2012
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moietyTamar Ginsburg-Shmuel, Michael Haas, Djordje Grbic, et al.
Molecular Endocrinology (Baltimore, Md.)|June 21, 2007
Phosphorylation of Irs1 at SER-522 inhibits insulin signalingJodel Giraud, Michael Haas, Edward P Feener, et al.
Organometallics|June 2, 2020
Sila-Peterson Reaction of Cyclic SilanidesAndreas W Kyri, Lukas Schuh, Andreas Knoechl, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trialDominik P Modest, Ruediger P Laubender, Sebastian Stintzing, et al.
Anticancer Research|December 26, 2012
Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapyKatharina Zeiss, Klaus G Parhofer, Volker Heinemann, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Investigative Radiology|September 10, 2003
Noninvasive diagnosis of arthritis by autofluorescenceAndreas Hansch, Dieter Sauner, Ingrid Hilger, et al.
Arthritis and Rheumatism|March 17, 2004
In vivo imaging of experimental arthritis with near-infrared fluorescenceAndreas Hansch, Oliver Frey, Dieter Sauner, et al.
World Journal of Gastroenterology|August 26, 2014
Translational research in pancreatic ductal adenocarcinoma: current evidence and future conceptsStephan Kruger, Michael Haas, Steffen Ormanns, et al.
International Journal of Molecular Medicine|November 13, 2003
Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesisWichard Vogel, Alexander Berndt, Angelika Müller, et al.
ACS Macro Letters|May 25, 2022
A Priori Prediction of Mass Spectrometric Product Patterns of Photoinitiated PolymerizationsPhilipp Jöckle, Judith Radebner, Michael Haas, et al.
Bioorganic & Medicinal Chemistry|August 21, 2012
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moietyTamar Ginsburg-Shmuel, Michael Haas, Djordje Grbic, et al.
Molecular Endocrinology (Baltimore, Md.)|June 21, 2007
Phosphorylation of Irs1 at SER-522 inhibits insulin signalingJodel Giraud, Michael Haas, Edward P Feener, et al.
Organometallics|June 2, 2020
Sila-Peterson Reaction of Cyclic SilanidesAndreas W Kyri, Lukas Schuh, Andreas Knoechl, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trialDominik P Modest, Ruediger P Laubender, Sebastian Stintzing, et al.
Anticancer Research|December 26, 2012
Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapyKatharina Zeiss, Klaus G Parhofer, Volker Heinemann, et al.
Pageof 18